Novartis
NVS
904 hedge funds and large institutions have $18.3B invested in Novartis in 2016 Q4 according to their latest regulatory filings, with 121 funds opening new positions, 302 increasing their positions, 354 reducing their positions, and 80 closing their positions.
51% more first-time investments, than exits
New positions opened: 121 | Existing positions closed: 80
21% more call options, than puts
Call options by funds: $98.8M | Put options by funds: $81.4M
3% more funds holding
Funds holding: 877 → 904 (+27)
0.62% more ownership
Funds ownership: 10.03% → 10.65% (+0.62%)
2% less capital invested
Capital invested by funds: $18.7B → $18.3B (-$411M)
15% less repeat investments, than reductions
Existing positions increased: 302 | Existing positions reduced: 354
25% less funds holding in top 10
Funds holding in top 10: 28 → 21 (-7)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$213M |
| 2 |
Dodge & Cox
San Francisco,
California
|
+$155M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$150M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$134M |
| 5 |
MNA
Manning & Napier Advisors
Fairport,
New York
|
+$130M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CI
Cambiar Investors
Denver,
Colorado
|
-$176M |
| 2 |
Mawer Investment Management
Calgary,
Alberta, Canada
|
-$59.4M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$36.3M |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$36.2M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$34M |
NVS Hedge Fund Activity: Q4 2016 in Review
904 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Novartis (NVS) for Q4 2016, worth a combined $18.3B — down 2.2% from $18.7B a quarter earlier.
Buyers outnumbered sellers: 121 funds opened new NVS positions and 80 closed out — a net gain of 41 holders — while 302 added to existing stakes and 354 trimmed.
The largest buyer was 1832 Asset Management, adding an estimated $213M. The largest seller was Cambiar Investors, exiting entirely with an estimated $176M sold.
- 904 institutional investors held Novartis (NVS) as of Q4 2016, up from 877 in Q3 2016.
- Funds reported $18.3B of Novartis stock for Q4 2016, down 2.2% quarter-over-quarter.
- 121 funds opened new Novartis positions in Q4 2016 and 80 closed out, a net change of +41 holders.
- The largest Novartis buyer in Q4 2016 was 1832 Asset Management, an estimated $213M added.
- The largest Novartis seller in Q4 2016 was Cambiar Investors, an estimated $176M sold.
Based on aggregated 13F filings for Q4 2016.